{"id":"https://openalex.org/W2035330461","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1586","title":"A Phase I Pharmacokinetic and Pharmacodynamic Study of S-3304, a Novel Matrix Metalloproteinase Inhibitor, in Patients with Advanced and Refractory Solid Tumors","display_name":"A Phase I Pharmacokinetic and Pharmacodynamic Study of S-3304, a Novel Matrix Metalloproteinase Inhibitor, in Patients with Advanced and Refractory Solid Tumors","publication_year":2007,"publication_date":"2007-04-01","ids":{"openalex":"https://openalex.org/W2035330461","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1586","mag":"2035330461","pmid":"https://pubmed.ncbi.nlm.nih.gov/17404091"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-06-1586","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1586","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-1586","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080538468","display_name":"Alberto Chiappori","orcid":"https://orcid.org/0000-0003-0810-7104","observed_orcids":["https://orcid.org/0000-0003-0810-7104"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alberto A. Chiappori","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida;","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida;","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046581734","display_name":"Sabine Eckhardt","orcid":"https://orcid.org/0000-0001-6958-5375","observed_orcids":["https://orcid.org/0000-0001-6958-5375"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Gail Eckhardt","raw_affiliation_strings":["2University of Colorado Cancer Center, Aurora, Colorado;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Colorado Cancer Center, Aurora, Colorado;","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112418138","display_name":"Ronald M. Bukowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald Bukowski","raw_affiliation_strings":["3Cleveland Clinic, Cleveland, Ohio;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cleveland Clinic, Cleveland, Ohio;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel M. Sullivan","raw_affiliation_strings":["1H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida;","University of South FLorida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida;","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"University of South FLorida","institution_ids":["https://openalex.org/I2613432"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109078895","display_name":"Minoru Ikeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Minoru Ikeda","raw_affiliation_strings":["5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048781163","display_name":"Yoshitaka Yano","orcid":"https://orcid.org/0000-0001-7787-883X","observed_orcids":["https://orcid.org/0000-0001-7787-883X"]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshitaka Yano","raw_affiliation_strings":["5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084251840","display_name":"Takuko Yamada\u2010Sawada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takuko Yamada-Sawada","raw_affiliation_strings":["5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yoshikaze Kambayashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshikaze Kambayashi","raw_affiliation_strings":["5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113786596","display_name":"Kazushige Tanaka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118477","display_name":"Shionogi (Japan)","ror":"https://ror.org/01v3bqg10","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210118477"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazushige Tanaka","raw_affiliation_strings":["5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Pharmaceutical R&D Division, Shionogi & Co. Ltd., Osaka, Japan","institution_ids":["https://openalex.org/I4210118477"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054771911","display_name":"Milind M. Javle","orcid":"https://orcid.org/0000-0001-9158-0941","observed_orcids":["https://orcid.org/0000-0001-9158-0941"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Milind M. Javle","raw_affiliation_strings":["4Roswell Park Cancer Institute, Buffalo, New York; and","GI Medical Oncology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Roswell Park Cancer Institute, Buffalo, New York; and","institution_ids":["https://openalex.org/I1292894508"]},{"raw_affiliation_string":"GI Medical Oncology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111567764","display_name":"Tarek M. Mekhail","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarek Mekhail","raw_affiliation_strings":["3Cleveland Clinic, Cleveland, Ohio;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cleveland Clinic, Cleveland, Ohio;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090647064","display_name":"Cindy L. O\u2019Bryant","orcid":"https://orcid.org/0000-0001-6337-2221","observed_orcids":["https://orcid.org/0000-0001-6337-2221"]},"institutions":[{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cindy L. O'Bryant","raw_affiliation_strings":["2University of Colorado Cancer Center, Aurora, Colorado;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Colorado Cancer Center, Aurora, Colorado;","institution_ids":["https://openalex.org/I4210134151"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111674028","display_name":"Patrick J. Creaven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J. Creaven","raw_affiliation_strings":["4Roswell Park Cancer Institute, Buffalo, New York; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Roswell Park Cancer Institute, Buffalo, New York; and","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5262,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":{"value":0.84513465,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"13","issue":"7","first_page":"2091","last_page":"2099"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/matrix-metalloproteinase-inhibitors","display_name":"matrix metalloproteinase inhibitors","score":0.9319999814033508},{"id":"https://openalex.org/keywords/mmp-2","display_name":"MMP-2","score":0.984000027179718},{"id":"https://openalex.org/keywords/mmp-9","display_name":"MMP-9","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8769999742507935},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9739999771118164},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7310000061988831},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9789999723434448},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.828000009059906},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.7360000014305115},{"id":"https://openalex.org/keywords/oral-anticancer-drugs","display_name":"oral anticancer drugs","score":0.6389999985694885},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.6299999952316284}],"concepts":[{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6796431541442871},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6671197414398193},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5677924156188965},{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.5603111386299133},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4943530559539795},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4821045696735382},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46079689264297485},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.43557584285736084},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37249141931533813},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13619184494018555},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020714","descriptor_name":"Maximum Tolerated Dose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020778","descriptor_name":"Matrix Metalloproteinase 2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020780","descriptor_name":"Matrix Metalloproteinase 9","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D061965","descriptor_name":"Matrix Metalloproteinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.ccr-06-1586","doi":"https://doi.org/10.1158/1078-0432.ccr-06-1586","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-06-1586","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:17404091","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17404091","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1504021012","https://openalex.org/W1531209766","https://openalex.org/W1767248573","https://openalex.org/W1965952846","https://openalex.org/W1977402941","https://openalex.org/W1984483611","https://openalex.org/W1990858735","https://openalex.org/W1994787439","https://openalex.org/W2003500892","https://openalex.org/W2102297522","https://openalex.org/W2139248078","https://openalex.org/W2142130238","https://openalex.org/W2162659554","https://openalex.org/W4207085250","https://openalex.org/W4239056163","https://openalex.org/W4246108968"],"related_works":["https://openalex.org/W4205620045","https://openalex.org/W4239056163","https://openalex.org/W4247058574","https://openalex.org/W2079455064","https://openalex.org/W4207085250","https://openalex.org/W7095308405","https://openalex.org/W1911901193","https://openalex.org/W2312295332","https://openalex.org/W2128938772","https://openalex.org/W1970508517"],"abstract_inverted_index":{"PURPOSE:":[0],"Matrix":[1],"metalloproteinases":[2],"(MMP)":[3],"play":[4],"a":[5,15,208,245],"fundamental":[6],"role":[7],"in":[8,30,37,69,81,190],"cancer":[9],"development":[10],"and":[11,25,33,61,71,90,94,100,113,120,155,160,219,229,249],"progression.":[12],"S-3304":[13,68,92,147,169,214],"is":[14,34,215,242],"potent,":[16],"orally":[17],"active,":[18],"noncytotoxic":[19],"inhibitor":[20],"of":[21,44,66,144,172,177,185],"MMPs,":[22],"primarily":[23],"MMP-2":[24,228],"MMP-9,":[26],"that":[27],"prolongs":[28],"survival":[29],"mice":[31],"xenografts":[32],"well":[35,217],"tolerated":[36,55,131],"healthy":[38],"volunteers.":[39],"EXPERIMENTAL":[40],"DESIGN:":[41],"The":[42,129,194],"aims":[43],"this":[45,248],"phase":[46],"I":[47],"clinical":[48],"trial":[49],"were":[50,95,106,123,126,141,150,163],"to":[51,192,204,226],"determine":[52],"the":[53],"maximum":[54,130],"dose,":[56],"dose-limiting":[57],"toxicities,":[58],"pharmacokinetic":[59],"profile,":[60],"intratumoral":[62,232],"MMP":[63,75,178,186,210,233,251],"inhibitory":[64,197,234],"activity":[65,76,179,187,198,211,235],"single-agent":[67],"advanced":[70],"refractory":[72],"solid":[73],"tumors.":[74],"was":[77,133,188,202],"determined":[78],"by":[79,152,180],"film":[80],"situ":[82],"zymography":[83],"(FIZ).":[84],"Patients":[85],"had":[86],"tumor":[87],"biopsies":[88],"before":[89],"after":[91],"administration":[93],"also":[96],"evaluated":[97],"for":[98,200],"response":[99],"survival.":[101],"RESULTS:":[102],"Four":[103],"dose":[104,132,137,166],"levels":[105],"explored":[107],"[DL1-DL4":[108],"or":[109],"800,":[110],"1,600,":[111],"2,400,":[112],"3200":[114],"mg":[115],"twice":[116],"daily":[117],"(BID),":[118],"respectively],":[119],"32":[121],"patients":[122,174],"enrolled.":[124],"Toxicities":[125],"mostly":[127],"gastrointestinal.":[128],"not":[134],"reached,":[135],"but":[136],"escalations":[138],"beyond":[139],"DL4":[140,201],"impractical":[142],"(number":[143],"capsules":[145],"needed).":[146],"steady-state":[148],"concentrations":[149,222],"reached":[151],"day":[153,156],"8,":[154],"1":[157],"mean":[158,183,196],"C(max)":[159],"AUC(0-8)":[161],"increases":[162],"less":[164],"than":[165],"proportional.":[167],"After":[168],"administration,":[170],"17":[171],"18":[173],"experienced":[175],"inhibition":[176,184],"FIZ.":[181],"Strong":[182],"observed":[189],"DL1":[191],"DL3.":[193],"negative":[195],"calculated":[199],"due":[203],"one":[205],"patient":[206],"with":[207,247],"397%":[209],"increase.":[212],"CONCLUSION:":[213],"safe,":[216],"tolerated,":[218],"achieves":[220],"plasma":[221],"above":[223],"those":[224],"required":[225],"inhibit":[227],"MMP-9.":[230],"Its":[231],"has":[236],"been":[237],"shown":[238],"using":[239],"FIZ,":[240],"which":[241],"useful":[243],"as":[244],"biomarker":[246],"other":[250],"inhibitors.":[252]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}